A teaspoon of your gut bacteria carries more than a thousand genes that can chemically tag their own DNA, and those tags may determine whether a high-fibre diet actually lowers your cholesterol. Obesity and heart disease are linked to diet, but the same meal can have wildly different metabolic effects in different people. Scientists know the gut microbiome plays a role, but they do not understand the molecular switches inside bacteria that translate food into health or harm. This project targets bacterial DNA methylation—chemical marks that turn bacterial genes on or off—as a missing piece of that puzzle. Until recently, these marks were too sparse and too difficult to map across entire bacterial genomes to study systematically. If the work succeeds, it could explain why some people benefit from a dietary change while others do not. That would allow clinicians to tailor nutritional advice to an individual’s gut bacterial epigenome, rather than issuing one-size-fits-all guidelines. It might also produce a stable, measurable biomarker—a bacterial methylation signature—that predicts cardiometabolic risk long before symptoms appear. The project is fundamentally mechanistic: it aims to uncover a molecular layer of host–microbe interaction that has been largely invisible, and in doing so, provide tools for more precise, prevention-focused dietary medicine.
View original technical description
Obesity and metabolic disease are a global health challenge and major risk factors for cardiovascular disease. Diet is a key modifiable risk factor for cardiometabolic disease but is challenging to study partly because metabolic response to diet is highly personalised. Diet exerts a major influence on the community of microbes in the human gut, the gut microbiota, which in turn plays a key role in metabolic health and disease. Understanding the links between diet, gut microbiota, and cardiometabolic health is crucial to provide tools to tackle the obesity crisis and its clinical consequences. Although diet-induced changes to the human gut microbiota have been identified in metabolic health and disease, our understanding of the bacterial molecular processes mediating these effects remains limited. DNA methylation of bacteria in our gut could play a key mechanistic role. Bacterial methylation has been under-explored at genome-wide scale, but recent developments in sequencing show that methylation is wide-spread, plays important roles including in regulation of bacterial gene function, and may provide a valuable stable biomarker of gene regulation. This project will characterise human gut bacterial methylation as a novel tool to uncover molecular pathways mediating diet impacts on cardiometabolic health. The hypothesis is that diet induces changes in bacterial methylation, which have functional consequences on the intestinal environment and its microbial community, and affect human health. The workflow includes 1/ diet intervention trials, 2/ large well-characterised cohorts, and 3/ functional experiments. The project will assess if diet-induced bacterial methylation marks together with bacterial methylation signatures of cardiometabolic traits can explain the inter-individual variability in metabolic response to diet, and its downstream effect on health. These novel mechanistic insights and tools will help to promote and optimise cardiometabolic disease prevention.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know